{"name":"Depomed","slug":"depomed","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"DM-1992","genericName":"DM-1992","slug":"dm-1992","indication":"Chronic pain","status":"phase_2"},{"name":"Diclofenac Potassium for Oral Solution","genericName":"Diclofenac Potassium for Oral Solution","slug":"diclofenac-potassium-for-oral-solution","indication":"Acute pain management","status":"marketed"},{"name":"Zipsor®","genericName":"Zipsor®","slug":"zipsor","indication":"Mild to moderate acute pain in adults","status":"marketed"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Gabapentin Extended Release","genericName":"Gabapentin Extended Release","slug":"gabapentin-extended-release","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Gabapentin Extended Release tablets","genericName":"Gabapentin Extended Release tablets","slug":"gabapentin-extended-release-tablets","indication":"Postherpetic neuralgia","status":"phase_3"}]}],"pipeline":[{"name":"DM-1992","genericName":"DM-1992","slug":"dm-1992","phase":"phase_2","mechanism":"DM-1992 is a small molecule that targets the central nervous system to treat pain.","indications":["Chronic pain"],"catalyst":""},{"name":"Diclofenac Potassium for Oral Solution","genericName":"Diclofenac Potassium for Oral Solution","slug":"diclofenac-potassium-for-oral-solution","phase":"marketed","mechanism":"Diclofenac potassium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing pain and inflammation.","indications":["Acute pain management","Mild to moderate pain with inflammation"],"catalyst":""},{"name":"Gabapentin Extended Release","genericName":"Gabapentin Extended Release","slug":"gabapentin-extended-release","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Gabapentin Extended Release tablets","genericName":"Gabapentin Extended Release tablets","slug":"gabapentin-extended-release-tablets","phase":"phase_3","mechanism":"Gabapentin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","indications":["Postherpetic neuralgia","Partial-onset seizures (adjunctive therapy)","Neuropathic pain conditions"],"catalyst":""},{"name":"Zipsor®","genericName":"Zipsor®","slug":"zipsor","phase":"marketed","mechanism":"Zipsor is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis and decrease inflammation and pain.","indications":["Mild to moderate acute pain in adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTFB1X0VIdm5nRVF0LVBnMTU5RDBvZVZtaVN1Sk5UQkFaQVdKOTdfYnVQam9QelRvcEhWRGhMSTBJWUZibm1YNjMzNWlROUhpX3ZjTmw3bHo5TVVDVXM5UTVyUTdkMFRpTXZNVWVTUFNqVDBYNGoxTjg0?oc=5","date":"2026-03-30","type":"pipeline","source":"Lawsuit Information Center","summary":"Depo Provera Lawsuit Settlement | April 2026 Litigation Update - Lawsuit Information Center","headline":"Depo Provera Lawsuit Settlement | April 2026 Litigation Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxNcVRkQmVxVW9mdDBnYl84X3RwSDNsWU5qaWRHZDM3aVBlcXIzeVEtRjNpT282b2cxMVUxU1JvVlRNd2g5c05YTV82NDV1QVVMYmxub0RxVHVPYWViYzJOY3BjOWMweEFuNnZiSkdsbEpGeXFQdUgyb0M5SVVnVUxRRTBmQ0tPYUdQSlFjVHk2dXlZV21pWmtJbkdCX2NUTlR0Qjd2WXVWU21iNEtkMW0w?oc=5","date":"2025-12-18","type":"regulatory","source":"Pharmaceutical Technology","summary":"FDA approves meningioma label warning on Pfizer’s contraceptive injection - Pharmaceutical Technology","headline":"FDA approves meningioma label warning on Pfizer’s contraceptive injection","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE1rdjkwTjlzYmhjbzQ4eTIxQW0xUVRwd1VJRC1KT3VSWmozZDl4YUFTOThXOXA2bG5XTkhxbktoNldiR1F3b1JhXzhsbndvQzhiMHpjdUdRaVhpaWFRN1JOWmZXeU53SE01dldUU3VVLThpLXB6eHhLRlZFbw?oc=5","date":"2025-10-08","type":"pipeline","source":"Jacobin","summary":"Big Pharma’s Legal Escape Hatch - Jacobin","headline":"Big Pharma’s Legal Escape Hatch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOU1dZYllhcW1KWG00RE1PR21TSnJUYjRaeDN6UnhtSFE4Rm5RN1VpUUpzWlMtclZBaW5ielU1OW5wRl82R2xLWEhES1Q0SUVqcDhUU0V1d1VnaXpBdkJIQTNBS1Vfb1BjX0ozVDBKaU9hYk0wbVc4RzNua29fdlotODAwcTg2Z1NyTC03b3NMQkNHREhjTGI0ejcwd2RUdnFF?oc=5","date":"2025-07-22","type":"pipeline","source":"Medical Marketing and Media","summary":"Inside the Depo-Provera battle: What medical marketers need to know - Medical Marketing and Media","headline":"Inside the Depo-Provera battle: What medical marketers need to know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNMmZpbzdWZ0xzU2dyMTZiN0RYcHpTVW1ETXhicHVSZElINlVPOEltYTEteU1jeDBORWlUajBfMXlxeVVFQmp2UnBDUDVFRGpmRTBYb3p3M0VqbDNSNmp0OWdsN1BOU05qdVloVnpXa1pvVWctVmE2cnNpaDNoSHZ6c0ptX0FxcWtQRVdrckNzMElRdVJveUJEV1NBWXRSckllLWFFZFVUVGltQ1dNN1ZBcnFKa3QyeVZWZlVYYkY4ZDk?oc=5","date":"2022-09-15","type":"pipeline","source":"umassmed.edu","summary":"Medication Use, Safety, and Evidence Project (MUSE) - umassmed.edu","headline":"Medication Use, Safety, and Evidence Project (MUSE)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNRzlwNEw2bHd0aTQ1bU9jenNMOUdfZ29XZ084UVlDbjVMeFFyVzRsaTZaTmxZNnRZRUFSa1RpNkFTYXBBR0Y1M0twbjFRVzZKd2IzUGdNUVRxcXV5OFFyTHpqSHZzdVpTRzVrNzNsZF83dDN4RGRPZ0ViZi1Pb1FCSG9oZHRyakJhdFhrTzQzZHA1M2xUb2JoVHdtZlZxNG5vMjRZUklBazh1ejdaZFhHZUpfYm1GUQ?oc=5","date":"2018-08-15","type":"pipeline","source":"Fierce Pharma","summary":"Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change - Fierce Pharma","headline":"Depomed joins ranks of scandal-plagued pharmas rehabbing their reputations with a name change","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQbWRkcThkd24yZHRnWWtka1NaMlpCeUdwZEk2UXZzVDhqcktQLWJLY3hjMVh6Q20xWVlsYjFoTV9fVEtTcjlQVTdIQ3RBeHRXTG5QTGFYb1M0WVpwTjZaakg4aXZMQmQyWlpFbGFiMTF4QVktMFplSVhDc0xnazVuWldkbDJrUWpNem1lWWJ1dWI?oc=5","date":"2018-04-03","type":"pipeline","source":"Fierce Biotech","summary":"Pharma vet Stan Bukofzer joins Depomed as CMO/CSO - Fierce Biotech","headline":"Pharma vet Stan Bukofzer joins Depomed as CMO/CSO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOVU9kRkp5aTItbkI0ZXRFV085eHNma05PejVVSlR5WnRoUFJlS05FQWp2MVR0NjdIMUJkZGhMZjRDQ21GcHNadFFtTnJLQ1lkdWRBMEhpOUROU1ZGRVF5RmZobXdPRmIxeXJrM2FPb3JyWGpYZ3V1RlhnVTVJVk51QkdKc1MwTGE0bGVn?oc=5","date":"2017-12-06","type":"pipeline","source":"Yahoo Finance","summary":"Depomed Executes an Exit Strategy for Its Opioid Drug - Yahoo Finance","headline":"Depomed Executes an Exit Strategy for Its Opioid Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPWFdBRndvSnU1VFE5bEJyZGFoSGdDR3lwNGprdmM5eGppMExaN2IwU2FTU2E0NkU3c0lJN3pvZ05rMmNWUEFfbkZ3R0hCeFAzcXd2NmhvTkVKaTVQeVVJZ3NYV2hjY3M2MjN5bGFzTWRnZU9lNEpwLXJQbDRfV2pRMkY3bEMwXzN4d2c?oc=5","date":"2017-03-29","type":"pipeline","source":"BioPharma Dive","summary":"Depomed appoints new CEO, board members at activist investor’s request - BioPharma Dive","headline":"Depomed appoints new CEO, board members at activist investor’s request","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNMmtQZlBYTHFNYVBsUkpQTUF0Y0xPSG5TamVOUEd3TDZCbHBDYVpnanBDY3lDdEhBWVYtY2RJbjQ2T05JSjJCU0NDZDF4OENuTzJmSjVpLV8ybm1vT1NxSlpaQWdsY1k4R0dpTTV1aVozWFVPZVBFVV8zQkVMSjZHUWlETEhnd2EtTk1kMER3?oc=5","date":"2016-06-02","type":"pipeline","source":"Contract Pharma","summary":"Developments in Orphan Drug Exclusivity After Depomed - Contract Pharma","headline":"Developments in Orphan Drug Exclusivity After Depomed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxQYWw3VmlBQmdHdF9FaUFBcXZsVy1OSUNGRzJ1UmxCU1JGaWJyLUlEdHZQSTV6cmtxbUM1QUFOdmIteXc4RmdOWXd2ZlJSbXBwajBfRjlGZ241QlV0aEx3a29uOW5vT3Z3MjlTWDVhMUZlWE1KR3Vndi1fNmg4WXdLcXZFdHEtaGM?oc=5","date":"2015-11-19","type":"pipeline","source":"WSJ","summary":"Horizon Pharma Withdraws Bid for Depomed - WSJ","headline":"Horizon Pharma Withdraws Bid for Depomed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTE1tUWUtMzMxZndqLTJEdXBGLXRiYXg0NGRHZi1qNmVSY0JWM3ZQMVdkeGNkaUlLa3FPSmRVeEdaUWhqX091NmZsX2lqM0x6bVA5RWFFUkRlQ3Y2Y01lSU9yR1lyR3o?oc=5","date":"2015-07-07","type":"pipeline","source":"Time Magazine","summary":"Ireland’s Horizon Pharma Launches Hostile, $3 billion Bid For U.S. Rival - Time Magazine","headline":"Ireland’s Horizon Pharma Launches Hostile, $3 billion Bid For U.S. Rival","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"phase_2":1,"marketed":3,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}